Preparation and evaluation of folate-decorated human serum albumin nanoparticles for the targeted delivery of sorafenib to enhance antihepatocarcinoma efficacy-Reference-Cited by-同舟云学术

Preparation and evaluation of folate-decorated human serum albumin nanoparticles for the targeted delivery of sorafenib to enhance antihepatocarcinoma efficacy

Published:2019-12 Issue: Volume:54 Page:101349
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Gao Wenhui,Jia Xiaoting,Wu Jinjun,Song Ying,Yin Jiang,Zhang Meimei,Qiu Ni,Li Xiaoyan,Wu Peng,Qi Xiaoxiao,Liu Zhongqiu

Funder

National Natural Science Foundation of China

Department of Science and Technology of Guangdong Province, China

Department of Education of Guangdong Province, China

Science and Technology Planning Program of Guangzhou, China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference43 articles.

1. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,2009

3. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis;Wilhelm;Cancer Res.,2004

4. Discovery and development of sorafenib: a multikinase inhibitor for treating cancer;Wilhelm;Nat. Rev. Drug Discov.,2006

5. Human serum albumin: a nanomedicine platform targeting breast cancer cells;Lee;J. Drug Deliv. Sci. Technol.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of sorafenib drug delivery system in the treatment of hepatocellular carcinoma: An update;Biomedicine & Pharmacotherapy;2024-08

2. Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor;Nano Today;2024-02

3. Albumin nanoparticles and their folate modified counterparts for delivery of a lupine derivative to hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2023-11

4. Metal Complexes in Target-Specific Anticancer Therapy: Recent Trends and Challenges;Journal of Chemistry;2022-05-17

5. Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment;Pharmaceutics;2021-12-25